Malaysia Halal pharmaceuticals – medicines that do not contain any alcohol, parts of animals such as dogs, pigs, bees, or any other substances prohibited as ‘haram’ under Shariah law – are becoming increasingly widespread globally. This trend is especially prevalent in the Asia Pacific region, where the significant Muslim populations of…
Singapore Dr Charles Stacey, president and CEO of Brain Health company Cerecin, formerly Accera, discusses the rebrand, new investment, the company’s relocation to Asia, and the upcoming rollout of a global Phase III clinical trial for its innovative new Alzheimer’s drug. As a small, innovative biotech company, we are looking…
Turkey Sule Mene, co-founder, president and CEO of Mene Health Group, shares with PharmaBoardroom the journey of her company starting as the first government-approved CRO of Turkey, its parallel growth alongside the increasingly prominent clinical trial environment of the country, evolution to becoming a value chain group of companies in clinical…
Portugal Lawyer Joana Silveira Botelho provides regular legal assistance to pharmaceutical companies and other entities of the health sector. Here she examines Portugal’s new regulatory framework on cannabis for medicinal purposes. What will actually change considering that in Portugal (and in the European Union) it is already possible to obtain a marketing…
Turkey Tuğçe Koç reveals how Onko Koçsel was able to quickly grow from an in-licenser to a production-oriented pharmaceutical company with an international reach. She also offers her take on how the Turkish healthcare sector could encourage more companies to grow and how existing companies can combat economic fluctuations. By…
France Pierre Moustial, CEO of URGO Group, explains the life-changing advancement in wound care treatments that URGO has been providing to patients all over the world as well as his upcoming plan to establish the company as a global leader by developing more innovative solutions in wound care and sleeping disorders.…
Spain Carlos Espina, managing director of COMSA Cleanroom Technology, a leading Spanish engineering firm, highlights the company’s great successes over the last few years, their international reach, and their strategy to maintain continued growth. As COMSA Corporación group has annual revenues of over EUR one billion, we only are looking…
Turkey Kazim Dinç, chairman of the board of SURDER and former Minister of Health of Turkey, offers his insights into the Turkish OTC and health products market, highlighting the challenges facing the industry and SURDER’s role in bringing about constructive reforms. Before SURDER was established, there was a sizeable gap…
Korea In an exclusive interview, Tae-Han Kim, president and CEO of Samsung Biologics, documents his strategy for expanding Samsung’s operations into biologics, and how Samsung Biologics has rapidly become one of the leading Contract Development Manufacturing Organisations (CDMO) in the market in only seven years. Dr Kim also provides his assessment…
Turkey Despite the sharp decline in the Turkish lira’s value, the general mood among pharmaceutical executives in Turkey is positive. Rather than being discouraged, they are calling upon their resiliency and experience from former periods of economic fluctuation to push the Turkish healthcare and life sciences sector forward. Turkey made…
Korea Professor Dukgeun Ahn of Seoul National University, trade policy advisor to the Ministry of Health offers his insights into the current policies towards the healthcare industry in Korea, and the potential implications for the US-Korea FTA renegotiations. The rate [of ageing] in Korea is actually even more serious than…
Spain Fernando Álvarez, director general of Allergan Iberia, highlights the market’s shift towards more holistic innovation and the company’s main growth drivers, especially in the field of aesthetics. Furthermore, he touches on the importance of the market access team in the fragmented Spanish healthcare ecosystem and his ambitions for Allergan throughout…
See our Cookie Privacy Policy Here